FDA Inspection
VitalantVitalant – FDA Inspection, Apr 12, 2022
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on April 12, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- April 12, 2022
- Product Type
- Biologics
View Company Profile
ID · 74a42180-2e05-4740-ad33-77c4778528dd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1167691
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 18, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1281750 - 2025-08-29
- FDA Inspection 1037711 - 2017-12-07
- FDA Inspection 979707 - 2016-07-21
- FDA Inspection 871353 - 2014-02-28
- FDA Inspection 784588 - 2012-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.